Reyataz

In the US, Reyataz (atazanavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

• Reyataz

UK matches:

• Reyataz 150 mg, 200 mg and 300mg Hard Capsules (SPC)

Ingredient matches for Reyataz

Atazanavir

Atazanavir is reported as an ingredient of Reyataz in the following countries:

• Argentina


• Belgium


• Chile


• Colombia


• Russian Federation

Atazanavir sulfate (a derivative of Atazanavir) is reported as an ingredient of Reyataz in the following countries:

• Australia


• Austria


• Bulgaria


• Canada


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Italy


• Japan


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Norway


• Portugal


• Romania


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.